Recent advances of nanovaccines on cancer theranostics

Recent advances of nanovaccines on cancer theranostics

Cancer is a leading cause of death worldwide, with an estimated 20 million new cancer cases and 9.7 million cancer deaths worldwide in 2022. Immunotherapy provides innovative strategies among the most groundbreaking developments in cancer treatment. Cancer vaccines, as a form of immunotherapy, have...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xiaobing Yuan, Tianyou Xu, Mubashir Hussain, Bin Liu, Jianwei Zhu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-02-01
Series:	Frontiers in Nanotechnology
Subjects:	nanoparticles nanovaccines immunotherapy cancer theranostics
Online Access:	https://www.frontiersin.org/articles/10.3389/fnano.2025.1521131/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Theranostic nanoemulsions suppress macrophage-mediated acute inflammation in rats
by: Riddhi Vichare, et al.
Published: (2025-02-01)

Targeted therapy and immunotherapy for gastric cancer: rational strategies, novel advancements, challenges, and future perspectives
by: Dong Luo, et al.
Published: (2025-02-01)

Phase II trial of nab-paclitaxel plus ramucirumab in combination with nivolumab for unresectable advanced or recurrent gastric cancer after progression on first-line treatment including fluoropyrimidine, platinum, and anti-PD-1/PD-L1 antibody (PADDLE)
by: Hidekazu Hirano, et al.
Published: (2025-02-01)

Personalized metronomic radiopharmaceutical therapy through injection profile optimization via physiologically based pharmacokinetic (PBPK) modeling
by: Aryan Golzaryan, et al.
Published: (2025-02-01)

Recent Advances in Chirally-Coupled Core Fibers
by: Mingheng Yuan, et al.
Published: (2022-07-01)

ITGA4 as a potential prognostic and immunotherapeutic biomarker in human cancer and its clinical significance in gastric cancer: an integrated analysis and validation
by: Jiaxing Zhang, et al.
Published: (2025-02-01)

Corrigendum: Recent advances in chirally-coupled core fibers
by: Mingheng Yuan, et al.
Published: (2025-02-01)

Harnessing nanoparticles for reshaping tumor immune microenvironment of hepatocellular carcinoma
by: JinSong Li, et al.
Published: (2025-02-01)

Mechanisms of T-cell Depletion in Tumors and Advances in Clinical Research
by: Xiangfei Su, et al.
Published: (2025-02-01)

A new strategy for the treatment of advanced ovarian cancer: utilizing nanotechnology to regulate the tumor microenvironment
by: Zixuan Xiong, et al.
Published: (2025-02-01)

Pre-injection of exosomes can significantly suppress ovarian cancer growth by activating the immune system in mice
by: Yuanyuan Wang, et al.
Published: (2025-02-01)

Immune microenvironment spatial landscapes of tertiary lymphoid structures in gastric cancer
by: Yi Xie, et al.
Published: (2025-02-01)

Case report: Patients with positive HER-2 amplification locally advanced gastroesophageal junction cancer achieved pathologic complete response with the addition of pembrolizumab to chemotherapy plus trastuzumab as neoadjuvant therapy
by: Huanhuan Li, et al.
Published: (2025-02-01)

Exosomes, their sources, and possible uses in cancer therapy in the era of personalized medicine
by: Tomas Zemanek, et al.
Published: (2024-12-01)

A comprehensive insight of innovations and recent advancements in nanocarriers for nose-to-brain drug targeting
by: Naeem Mubarak, et al.
Published: (2025-12-01)

Engineered CAF-cancer cell hybrid membrane biomimetic dual-targeted integrated platform for multi-dimensional treatment of ovarian cancer
by: Yuwei Yao, et al.
Published: (2025-02-01)

Vaccine adjuvants for immunotherapy: type, mechanisms and clinical applications
by: Nimeet Desai, et al.
Published: (2025-02-01)

Small cell lung cancer with EML4-ALK fusion: report of a case responding to ALK TKI and literature review
by: Mingyue Wang, et al.
Published: (2025-02-01)

Targeting HVEM-GPT2 axis: a novel approach to T cell activation and metabolic reprogramming in non-small cell lung cancer therapy
by: Yuanshan Yao, et al.
Published: (2025-02-01)

Survival and risk factors for metastatic colorectal cancer patients with a history of prior malignancy
by: Yiwen Qiu, et al.
Published: (2025-02-01)

Targeted therapeutic strategies for Nectin-4 in breast cancer: Recent advances and future prospects
by: Yufei Wang, et al.
Published: (2025-02-01)

Mitochondria-targeted photothermal-chemodynamic therapy enhances checkpoint blockade immunotherapy on colon cancer
by: Benchao Zheng, et al.
Published: (2025-04-01)

Integration of single-cell and bulk RNA-sequencing data to construct and validate a signature based on NK cell marker genes to predict immunotherapy response and prognosis in colorectal cancer
by: Xiaoyu Qin, et al.
Published: (2025-02-01)

Bibliometric insight into neoadjuvant immunotherapy in non-small cell lung cancer: trends, collaborations, and future avenues
by: Pengliang Xu, et al.
Published: (2025-02-01)

Platycodon grandiflorum-derived extracellular vesicles suppress triple-negative breast cancer growth by reversing the immunosuppressive tumor microenvironment and modulating the gut microbiota
by: Min Yang, et al.
Published: (2025-02-01)

Identification and validation of TSPAN13 as a novel temozolomide resistance-related gene prognostic biomarker in glioblastoma.
by: Haofei Wang, et al.
Published: (2025-01-01)

Effects of Dust Event Days on Influenza: Evidence from Arid Environments in Lanzhou
by: Ling Zhang, et al.
Published: (2022-10-01)

Brief report: impact of consolidation durvalumab on unresectable non-small cell lung cancer with driver mutations
by: Jason C.S. Ho, et al.
Published: (2024-01-01)

Why PD-L1 expression varies between studies of lung cancer: results from a Bayesian meta-analysis
by: Preston Ngo, et al.
Published: (2025-02-01)

Molecular anti-tumorigenic mechanism of Radix Polygoni Multiflori-derived exosome-like nanoparticles
by: Mingqing Yang, et al.
Published: (2025-02-01)

Highly efficient assessment and selective determination of pancreatic cancer biomarker CA-19-9 using co-electrodeposited MXene-AgNPs nanocomposite
by: Mahsa Mirzayi, et al.
Published: (2025-02-01)

Production of novel theranostic nano-vector based on superparamagnetic iron oxide nanoparticles/miR-497 targeting colorectal cancer
by: Asmaa M. Elfiky, et al.
Published: (2025-02-01)

Recent advances in nanomaterials and their mechanisms for infected wounds management
by: Jianping Zhu, et al.
Published: (2025-04-01)

PSMA antibody, humanized PSMA.CAR10.3, or Cetuximab increases prostate cancer localization of NF-κB p50-deficient immature myeloid cells (p50-IMC) and phagocytosis by their macrophage progeny
by: Mohammad A. Alzubi, et al.
Published: (2025-02-01)

CAV1 promotes epithelial-to-mesenchymal transition (EMT) and chronic renal allograft interstitial fibrosis by activating the ferroptosis pathway
by: Qianguang Han, et al.
Published: (2025-02-01)

Harnessing amino acid pathways to influence myeloid cell function in tumor immunity
by: Jiongli Pan, et al.
Published: (2025-02-01)

Exploring the role and mechanisms of MAGEA4 in tumorigenesis, regulation, and immunotherapy
by: Weijian Zhu, et al.
Published: (2025-02-01)

Psoriasis: Unraveling Disease Mechanisms and Advancing Pharmacological and Nanotechnological Treatments
by: Miao M, et al.
Published: (2025-02-01)

Editorial: Immunity and pulmonary vascular diseases: challenges, advances and future perspectives
by: Qi Jin, et al.
Published: (2025-02-01)

Integrative analysis of 5-methylcytosine associated signature in papillary thyroid cancer
by: Ying Ding, et al.
Published: (2025-02-01)